Proto Labs Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Proto LabsDer Gewinn des Unternehmens wird voraussichtlich um 11.5% pro Jahr sinken, während der Jahresumsatz voraussichtlich um 3% pro Jahr wachsen wird. Der Gewinn pro Aktie wird voraussichtlich zurückgehen.

Wichtige Informationen

-11.5%

Wachstumsrate der Gewinne

-1.1%

EPS-Wachstumsrate

Machinery Gewinnwachstum	9.0%
Wachstumsrate der Einnahmen	3.0%
Zukünftige Eigenkapitalrendite	n/a
Analystenabdeckung	Low
Zuletzt aktualisiert	04 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Proto Labs Non-GAAP EPS of $0.26 beats by $0.05, revenue of $115.6M beats by $5.47M

Feb 10

Proto Labs: Transitioning From A Fast Grower To A Slow Grower

Jan 20

Some Investors May Be Worried About Proto Labs' (NYSE:PRLB) Returns On Capital

Dec 21

Proto Labs Q3 2022 Earnings Preview

Nov 03

Proto Labs: Improvement Of The Digital Model And Undervalued

Oct 27

Is It Too Late To Consider Buying Proto Labs, Inc. (NYSE:PRLB)?

Sep 12

Protolabs names new technology chief

Sep 08

Some Investors May Be Worried About Proto Labs' (NYSE:PRLB) Returns On Capital

Aug 05

Proto Labs Q2 2022 Earnings Preview

Aug 04

Proto Labs: Not A Great Prospect Until Profitability Issues Clear Up

Jul 07

Is Proto Labs, Inc. (NYSE:PRLB) Potentially Undervalued?

May 24

Proto Labs (NYSE:PRLB) Could Be Struggling To Allocate Capital

Mar 30

The Prognosis For Proto Labs

Feb 22

Returns On Capital At Proto Labs (NYSE:PRLB) Paint A Concerning Picture

Nov 28

Is There Now An Opportunity In Proto Labs, Inc. (NYSE:PRLB)?

Nov 10

Proto Labs: A Play On Additive Manufacturing

Nov 04

Investors Could Be Concerned With Proto Labs' (NYSE:PRLB) Returns On Capital

Aug 29

Some Investors May Be Willing To Look Past Proto Labs' (NYSE:PRLB) Soft Earnings

Aug 14

Estimating The Fair Value Of Proto Labs, Inc. (NYSE:PRLB)

Aug 04

Gewinn- und Umsatzwachstumsprognosen

NYSE:PRLB - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	550	N/A	N/A	N/A	1
12/31/2025	512	20	N/A	N/A	4
12/31/2024	499	19	N/A	N/A	5
9/30/2024	504	24	51	78	N/A
6/30/2024	509	25	49	77	N/A
3/31/2024	506	20	45	72	N/A
12/31/2023	504	17	45	73	N/A
9/30/2023	494	-105	51	67	N/A
6/30/2023	485	-109	40	63	N/A
3/31/2023	490	-106	45	67	N/A
12/31/2022	488	-103	40	62	N/A
9/30/2022	496	24	52	75	N/A
6/30/2022	500	24	49	66	N/A
3/31/2022	496	35	36	67	N/A
12/31/2021	488	33	21	55	N/A
9/30/2021	470	31	22	57	N/A
6/30/2021	452	41	37	74	N/A
3/31/2021	435	41	51	91	N/A
12/31/2020	434	51	60	107	N/A
9/30/2020	441	56	58	115	N/A
6/30/2020	451	59	53	115	N/A
3/31/2020	460	62	58	120	N/A
12/31/2019	459	64	54	116	N/A
9/30/2019	460	68	50	122	N/A
6/30/2019	458	72	40	119	N/A
3/31/2019	451	74	40	115	N/A
12/31/2018	446	77	36	123	N/A
9/30/2018	427	72	37	108	N/A
6/30/2018	400	64	N/A	102	N/A
3/31/2018	372	58	N/A	89	N/A
12/31/2017	344	52	N/A	82	N/A
9/30/2017	323	47	N/A	78	N/A
6/30/2017	313	46	N/A	78	N/A
3/31/2017	306	44	N/A	78	N/A
12/31/2016	298	43	N/A	77	N/A
9/30/2016	299	45	N/A	75	N/A
6/30/2016	289	46	N/A	69	N/A
3/31/2016	278	47	N/A	61	N/A
12/31/2015	264	47	N/A	64	N/A
9/30/2015	246	45	N/A	58	N/A
6/30/2015	233	43	N/A	59	N/A
3/31/2015	222	42	N/A	57	N/A
12/31/2014	210	42	N/A	57	N/A
9/30/2014	198	41	N/A	54	N/A
6/30/2014	185	39	N/A	55	N/A
3/31/2014	172	37	N/A	53	N/A
12/31/2013	163	35	N/A	48	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: PRLBFür die nächsten 3 Jahre wird ein Rückgang der Gewinne prognostiziert (-11.5% pro Jahr).

Ertrag vs. Markt: PRLBFür die nächsten 3 Jahre wird ein Rückgang der Gewinne prognostiziert (-11.5% pro Jahr).

Hohe Wachstumserträge: PRLBFür die nächsten 3 Jahre wird mit einem Rückgang der Erträge gerechnet.

Einnahmen vs. Markt: PRLBDie Einnahmen des Unternehmens (3% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.9% pro Jahr).

Hohe Wachstumseinnahmen: PRLBDie Einnahmen des Unternehmens (3% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von PRLB in 3 Jahren voraussichtlich hoch sein wird

Proto Labs Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Consensus EPS estimates increase by 14%

Proto Labs, Inc. Provides Earnings Guidance for the Fourth Quarter of 2024

Consensus EPS estimates fall by 24%

Proto Labs, Inc. Provides Earnings Guidance for the Third Quarter of 2024

Proto Labs, Inc. Provides Earnings Guidance for the First Quarter and for Full Year 2024

Price target decreased by 7.8% to US$37.50

Recent updates

Proto Labs' (NYSE:PRLB) Performance Is Even Better Than Its Earnings Suggest

Consensus EPS estimates increase by 14%

New major risk - Revenue and earnings growth

Proto Labs, Inc.'s (NYSE:PRLB) 36% Jump Shows Its Popularity With Investors

Proto Labs, Inc. Provides Earnings Guidance for the Fourth Quarter of 2024

Second quarter 2024 earnings released: EPS: US$0.18 (vs US$0.015 loss in 2Q 2023)

Investor sentiment improves as stock rises 42%

Proto Labs, Inc. to Report Q3, 2024 Results on Nov 01, 2024

President recently bought US$100k worth of stock

Here's What's Concerning About Proto Labs' (NYSE:PRLB) Returns On Capital

Proto Labs: Defensive Strategy Not Paying Off Yet

Consensus EPS estimates fall by 24%

New major risk - Revenue and earnings growth

Second quarter 2024 earnings: EPS misses analyst expectations

Investor sentiment deteriorates as stock falls 19%

Proto Labs, Inc. Provides Earnings Guidance for the Third Quarter of 2024

Now 22% undervalued

Calculating The Intrinsic Value Of Proto Labs, Inc. (NYSE:PRLB)

Proto Labs, Inc. to Report Q2, 2024 Results on Aug 02, 2024

Proto Labs: Interesting Crossroads

Now 21% undervalued after recent price drop

Proto Labs' (NYSE:PRLB) Solid Earnings Are Supported By Other Strong Factors

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Proto Labs, Inc., Annual General Meeting, May 23, 2024

Proto Labs, Inc. to Report Q1, 2024 Results on May 03, 2024

Proto Labs, Inc.'s (NYSE:PRLB) Price In Tune With Revenues

Insufficient new directors

Proto Labs: Cash Flows Are Supporting The Stock

Proto Labs: Excellent Business Feats Yet To Financially Materialize

Full year 2023 earnings: EPS exceeds analyst expectations

New major risk - Revenue and earnings growth

Proto Labs, Inc. Provides Earnings Guidance for the First Quarter and for Full Year 2024

Proto Labs, Inc. to Report Q4, 2023 Results on Feb 09, 2024

Proto Labs (NYSE:PRLB) May Have Issues Allocating Its Capital

Price target decreased by 7.8% to US$37.50

Proto Labs: Overlooked Digital Manufacturing Opportunity

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Proto Labs, Inc. to Report Q3, 2023 Results on Nov 03, 2023

Protolabs Appoints Agnes Semington as Chief Human Resources Officer

Proto Labs Remains Profitable Despite So Much Pessimism

Second quarter 2023 earnings: EPS misses analyst expectations

Proto Labs, Inc. to Report Q2, 2023 Results on Aug 04, 2023

Proto Labs: The Rally Appears Overdone

Be Wary Of Proto Labs (NYSE:PRLB) And Its Returns On Capital

Proto Labs, Inc.(NYSE:PRLB) dropped from Russell 2000 Value-Defensive Index

Proto Labs, Inc. Provides Earnings Guidance for the Second Quarter of 2023

Is There An Opportunity With Proto Labs, Inc.'s (NYSE:PRLB) 41% Undervaluation?

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Proto Labs (NYSE:PRLB) Might Be Having Difficulty Using Its Capital Effectively

Protolabs Launches Instant Manufacturability Analysis for 3D Printing

Full year 2022 earnings: EPS misses analyst expectations

Proto Labs, Inc. Provides Financial Guidance for the First Quarter of 2023

Proto Labs Non-GAAP EPS of $0.26 beats by $0.05, revenue of $115.6M beats by $5.47M

Investor sentiment improves as stock rises 16%

Proto Labs, Inc. to Report Q4, 2022 Results on Feb 10, 2023

Proto Labs: Transitioning From A Fast Grower To A Slow Grower

Some Investors May Be Worried About Proto Labs' (NYSE:PRLB) Returns On Capital

Price target decreased to US$34.50

Investor sentiment deteriorated over the past week

Proto Labs, Inc. Provides Financial Guidance for the Fourth Quarter of 2022

Price target decreased to US$34.50

Proto Labs Q3 2022 Earnings Preview

Proto Labs: Improvement Of The Digital Model And Undervalued

Proto Labs, Inc. to Report Q3, 2022 Results on Nov 04, 2022

Is It Too Late To Consider Buying Proto Labs, Inc. (NYSE:PRLB)?

Proto Labs, Inc. Appoints Oleg Ryaboy as New Chief Technology Officer

Protolabs names new technology chief

Consensus EPS estimates fall by 14%

Price target decreased to US$47.50